Today, Research to Prevent Blindness (RPB) and more than 30 other organizations are convening in Washington DC for the Vision Research Funding Partnership event, which was organized around the theme of “The Research Pipeline – From Premise to Patient.”
Research suggests that Medicare reimbursements for complex cataract surgery cover less than two minutes of operating time, and an increase to reimbursements for the procedure may be justified. Complex cataract surgery requires more time and resources than simple cataract surgery, and this study indicates that the incremental reimbursement for the complex surgery is not enough to offset the increased costs.
Below is a brief roundup of news and story ideas from the experts at UCLA Health. For more information on these stories or for help on other stories, please contact us at [email protected].
An advanced surgical therapy has proved considerably more efficacious than conventional treatments for patients with melanoma in the eye (uveal) that has spread to the liver, a University of Gothenburg study shows.
Patients with a family history of age-related macular degeneration (AMD), the leading cause of permanent vision loss in those older than 60, should visit an ophthalmologist by age 55 to be screened for signs of the disease, advises an expert at UT Southwestern Medical Center.
Staphylococcus aureus, Clostridioides difficile, Candida auris, Drug-resistant Shigella. These bacteria not only have difficult names to pronounce, but they are also difficult to fight off. These bacteria may infect humans and animals, and the infections they cause are harder to treat than those caused by non-resistant bacteria. Antimicrobial resistance is an urgent global public health threat.
Researchers in China have successfully restored the vision of mice with retinitis pigmentosa, one of the major causes of blindness in humans. The study, to be published March 17 in the Journal of Experimental Medicine, uses a new, highly versatile form of CRISPR-based genome editing with the potential to correct a wide variety of disease-causing genetic mutations.
Using vision to efficiently move through an area by foot uses a unique region of the brain’s cortex, according to a small study funded by the National Eye Institute (NEI).
Researchers supported by the National Eye Institute are developing artificial intelligence/machine learning (AI/ML)-based systems that not only screen for AMD but also predict which patients will likely progress to late within two years. The systems also evaluate separately one’s risk for developing late wet (neovascular) AMD from one’s risk for late dry (geographic atrophy) AMD.
Shaffer Grants provide seed funds to bold investigators whose creative projects explore promising leads and show strong potential for impact on glaucoma.
Stuart Therapeutics, Inc., a clinical-stage ophthalmic biopharmaceutical company focused on developing therapies for the treatment of anterior segment, refractive and posterior segment eye disorders, today announced that it is sponsoring two research poster presentations by researchers at Vanderbilt University and the University of Rochester at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting, which will take place from April 23-27, 2023, in New Orleans, Louisiana.
Cedars-Sinai investigators have produced the most extensive analysis to date of changes in the retina—a layer of tissue at the back of the eye where visual information originates—and how those retinal changes correspond to brain and cognitive changes in Alzheimer’s disease patients.
Dr. Seol Seung-Kwon's team at the Korea Electrotechnology Research Institute published in international journals, implementing augmented reality by meniscus-guided printing.
Questions remain about artificial tears linked to an outbreak of Pseudomonas aeruginosa infections involving 64 people in 13 states, including 8 cases of vision loss, as well as lung and urinary tract infections, and one death. Federal agencies warned people to stop using EzriCare and Delsam Pharma artificial tears after tests of opened bottles used by those affected found a rare, extensively drug-resistant strain of P. aeruginosa. The strain had never been reported in the United States.What is clear is that eye health experts have advice for people using artificial tears, which are sold over the counter and widely used for eye irritation associated with dry eye disease, contact lens use, and refractive surgery, as well among those using other eye drops regularly, such as for glaucoma.
Face blindness, a mystifying condition that can trick us into believing we recognize people we’ve never met or make us fail to recognize those we have, has been previously estimated to affect between 2 and 2.5 percent of people in the world.
Now, a new study by researchers at Harvard Medical School (HMS) and the VA Boston Healthcare System is providing fresh insights into the disorder, suggesting it may be more common than currently believed.
The SLAS Discovery Editor's Top 10 annually showcases ten individual articles that stand out as the most innovative scientific achievements published in SLAS Discovery in the past 12 months.
The 2023 Shaffer Prize for Innovative Glaucoma Research recognizes two Shaffer Grant recipients whose projects best exemplify the pursuit of breakthrough ideas in the quest to better understand and cure glaucoma.
An international team of researchers led by Lithuanian scientists provide additional evidence that intracranial pressure plays an important role in normal-tension glaucoma, which accounts for up to 50 per cent of all glaucoma cases.
While early treatment of diabetes-related eye disease slowed progression to severe disease, it did not improve visual acuity compared with treating more severe disease once it developed, according to a clinical study from the DRCR Retina Network.
Researchers at Tel Aviv University identified a new genetic risk factor for the complex eye disease AMD (Age-related Macular Degeneration), a leading cause for loss of eyesight at an advanced age.
The American Macular Degeneration Foundation will be hosting
multiple, awareness-spreading activities throughout February, which is AMD Awareness Month, including new films on living well with AMD.
Glaucoma is a common ocular disease in which the optic nerve malfunctions due to the increased intraocular pressure (IOP) caused by drainage canal blocking in the eye.
A new survey of Americans 40 and older reveals a concerning lack of knowledge about the leading cause of blindness and vision loss among older adults, age-related macular degeneration (AMD).
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) congratulates Tasneem Khatib DM, FRCOphth—recipient of the 2022 Point of View Award.
Established by the Point of View Foundation (Fundació Punt de Vista), the award provides a $20,000 cash prize in recognition of an outstanding scholarly article related to efforts to restore vision through regenerative ophthalmology, biotechnology, whole eye transplantation or other approaches.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today that the 2023 recipient of the Oberdorfer Award in Low Vision Research is Lisa Ostrin, OD, PhD, FARVO. In recognition of this achievement, she will receive a $1,250 honorarium, an inscribed award and invitations to special events at the ARVO Annual Meeting. She will also present a lecture during an invited speaker session at ARVO 2023.
The Association for Research in Vision and Ophthalmology (ARVO) announced today the 2023 recipients of the Dr. David L. Epstein Award:Since 2016, the Dr. David L. Epstein Award has been given annually to a well-established senior investigator with a documented history of conducting eye and vision research in glaucoma and of mentoring clinician-scientists to independent academic and research careers.
People with diabetes who experience periods of low blood sugar — a common occurrence in those new to blood sugar management — are more likely to have worsening diabetic eye disease. Now, researchers at Johns Hopkins Medicine say they have linked such low blood sugar levels with a molecular pathway that is turned on in oxygen-starved cells in the eye.
A total of 13 physicians at Mercy Medical Center representing multiple specialties have been named “Top Doctors” by Castle Connolly Medical Ltd. Castle Connolly identifies top doctors, both nationally and regionally, based on an extensive nominations process open to all licensed physicians in the United States.
Patients undergoing cataract surgery typically have their natural lens replaced with an artificial intraocular lens (IOL). But complications occasionally arise that require the placement of a more surgically challenging secondary IOL. Several techniques are available for secondary IOL placement, and each has its advantages and disadvantages.
The Association for Research in Vision and Ophthalmology (ARVO) Foundation announced today the recipients of the 2023 Pfizer Ophthalmics Carl Camras Translational Research Award:Granted annually to young investigators working in areas of translational research, each recipient will be awarded $12,000.
For a translator to turn one language (say, English) into another (say, Greek), she has to be able to understand both languages and what common meanings they point to, because English is not very similar to Greek.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Miguel Flores-Bellver, PhD, recipient of the 2023 Bert M. Glaser, MD Award for Innovative Research in Retina. The award recognizes an early-career investigator who has made a novel discovery that impacted the understanding and/or treatment of a retinal disease or condition.
Rockville, Md.—The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Demetrios G. Vavvas, MD, PhD, the 2022 recipient of the Kreissig Award for Excellence in Retinal Surgery. Established by Ingrid Kreissig, MD, through the ARVO Foundation, the $30,000 award recognizes excellence in the understanding of the mechanisms of retinal disease requiring surgical management, innovative approaches to management, and/or outcomes of surgical treatment.
Researchers discover new clues for causes of adult-onset macular degeneration.
Not for public release
This news release is embargoed until 16-Jan-2023 5:00 PM EST
Released to reporters: 10-Jan-2023 2:00 PM EST
A reporter's PressPass is required to
access this story until the embargo expires on 16-Jan-2023 5:00 PM EST
The Newswise PressPass gives verified journalists access to embargoed stories.
Please log in to complete a presspass application.
If you have not yet registered, please Register. When you
fill out the registration form, please identify yourself as a reporter in order to
advance to the presspass application form.
The Association for Research in Vision and Ophthalmology (ARVO) announced today the recipients of the 2023 ARVO Foundation Collaborative Research Fellowship: José Arthur Milhomens Filho, MD; Maria Constanza Paz, PhD; Raba Thapa, PhD.With the goal of strengthening ophthalmic research capacities worldwide, the Fellowship pairs early-career researchers from developing countries with collaborating scientists in well-established research laboratories.
The Association for Research in Vision and Ophthalmology (ARVO) Foundation congratulates Edmund Arthur, OD, PhD, the 2023 recipient of the Genentech Career Development Award for Underrepresented Minority (URM) Emerging Vision Scientists. Arthur will receive a two-year grant totaling $100,000 to support research and personnel costs for establishing an independent vision research program.
Patients considering LASIK vision correction surgery should weigh the risks as well as benefits and see a doctor who can assess whether they are a good candidate for the procedure, according to an ophthalmologist at UT Southwestern Medical Center.
Benjamin K. Mizell, MD, an anesthesiologist with a proven track record of leading major Mass Eye and Ear initiatives including its electronic medical record integration, has been named chief of Anesthesia at Mass Eye and Ear.
Scientists at the National Eye Institute (NEI) have developed a zebrafish model of NEDBEH—a rare genetic disorder that can cause coloboma, where parts of the eye are missing due to developmental defects. The model provides a new tool for understanding the eye's embryonic development. The NEI is part of the National Institutes of Health.